Tag Archive | "Class Action"
Government report links Avandia to heart attacks
The diabetes drug Avandia produced by GlaxoSmithKline is linked with tens of thousands of heart attacks, and drugmaker GlaxoSmithKline knew of the risks for years but worked to keep them from the public, according to a Senate committee report released on 20., February of 2010. The senate report by the Senate Finance Committee also criticized the FDA, [...]
Continue reading...Avandia Drug Recall
Tuesday, January 20, 2009
Avandia produced by GlaxoSmithKline, is an oral diabetes medication intended to help those with type-2 diabetes better control their blood glucose levels. Generically classified as a thiazoliodinedione, Avandia is not indicated for those with insulin-dependent (type-1) diabetes. FDA scientists estimated in July 2007 that Avandia was associated with approximately 83,000 heart attacks since the drug came to [...]
Continue reading...Arthritis Drug Vioxx Recalled
Sunday, July 27, 2008
Arthritis drug Vioxx (Rofecoxib) was recalled by Merck & Co., Inc. The Vioxx recall was voluntarily started by Merck to discontinue the COX-2 inhibitor in September, 2004. Person’s affected by the Vioxx side effects are urged to seek medical and legal help. The Vioxx Recall was prompted after a three year trial known as Adenomatous Polyp [...]
Continue reading...Trasylol Class Action Lawsuit Recall
Sunday, July 27, 2008
FDA recently issued a public health advisory about the possibility of serious side effects from Trasylol (aprotinin), a drug used to prevent perioperative blood loss in patients undergoing CABG surgery. The advisory was based on two recently published observational studies. One reported that Trasylol may be associated with an increased risk of MI, stroke and renal [...]
Continue reading...
Saturday, February 20, 2010
0 Comments